Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.

Höftberger R, Garzuly F, Dienes HP, Grubits J, Rohonyi B, Fischer G, Hanzely Z, Lassmann H, Budka H.

Mult Scler. 2007 Nov;13(9):1100-6.

PMID:
17967838
2.

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.

Hirotani M, Nakano H, Ura S, Yoshida K, Niino M, Yabe I, Sasaki H.

Intern Med. 2009;48(5):373-5. Epub 2009 Mar 2.

3.

Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.

Ghilardi G, Gonvers JJ, So A.

Br J Rheumatol. 1998 Dec;37(12):1349-51.

PMID:
9973163
4.

Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?

Bosi E, Minelli R, Bazzigaluppi E, Salvi M.

Diabet Med. 2001 Apr;18(4):329-32.

PMID:
11437866
5.

Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis.

Cadoni G, Marinelli L, De Santis A, Romito A, Manna R, Ottaviani F.

J Laryngol Otol. 1998 Oct;112(10):962-3.

PMID:
10211222
6.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
8.

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.

J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. Epub 2007 Jun 12.

PMID:
17565587
9.

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.

Meriggioli MN, Rowin J.

Muscle Nerve. 2000 Mar;23(3):433-5.

PMID:
10679722
10.

Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.

Martocchia A, Labbadia G, Paoletti V, Gargano S, Grossi A, Trabace S, Musca A, Falaschi P.

Neuro Endocrinol Lett. 2001;22(1):49-52.

PMID:
11335880
11.

Multiple sclerosis-like disease secondary to alpha interferon.

Matsuo T, Takabatake R.

Ocul Immunol Inflamm. 2002 Dec;10(4):299-304.

PMID:
12854039
12.

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P.

Gastroenterology. 2008 Sep;135(3):821-9. doi: 10.1053/j.gastro.2008.05.044. Epub 2008 May 21.

PMID:
18593587
13.

Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.

Andrade LJ, Atta AM, D'Almeida Junior A, Paraná R.

Braz J Infect Dis. 2008 Apr;12(2):144-8. Review.

14.

Restless legs syndrome due to interferon-alpha.

LaRochelle JS, Karp BI.

Mov Disord. 2004 Jun;19(6):730-1.

PMID:
15197722
15.
16.

Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P.

Arthritis Rheum. 2008 Feb;58(2):604-11. doi: 10.1002/art.23305.

17.

Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.

Urbani S, Amadei B, Tola D, Pedrazzi G, Sacchelli L, Cavallo MC, Orlandini A, Missale G, Ferrari C.

J Hepatol. 2008 Apr;48(4):548-58. doi: 10.1016/j.jhep.2007.12.014. Epub 2008 Jan 28. Erratum in: J Hepatol. 2008 Sep;49(3):483.

PMID:
18280607
18.

Host factors and failure of interferon-alpha treatment in hepatitis C virus.

Gao B, Hong F, Radaeva S.

Hepatology. 2004 Apr;39(4):880-90. Review.

PMID:
15057887
19.

Interferon-induced depression in chronic hepatitis C.

Horsmans Y.

J Antimicrob Chemother. 2006 Oct;58(4):711-3. Epub 2006 Sep 2.

PMID:
16951413
20.

[Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].

Napoli N, Tortorella C, Deramo MT, Antonaci A, Parisi CV, Antonaci S.

Recenti Prog Med. 2004 Nov;95(11):525-8. Italian.

PMID:
15598090

Supplemental Content

Support Center